Lv54
1280 积分 2025-04-07 加入
Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy
1个月前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
1个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
1个月前
已完结
A Novel Attenuated CD122-Biased IL15 Mutein Promotes Strong NK and T Cell-Dependent Antitumor Immunity
1个月前
已完结
Tumour-intrinsic resistance to immune checkpoint blockade
2个月前
已完结
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
2个月前
已完结
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
2个月前
已完结
Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity
2个月前
已完结
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike “Non-Alpha” Muteins
2个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
皖公网安备34019202002308
